PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptHHS Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
 
Mol Cancer Ther. Author manuscript; available in PMC 2010 September 15.
Published in final edited form as:
Mol Cancer Ther. 2010 May; 9: 1482.
doi:  10.1158/1535-7163.MCT-10-0322
PMCID: PMC2939859
NIHMSID: NIHMS194856

Correction: Tautomycetin and Tautomycin Suppress the Growth of Medullary Thyroid Cancer Cells via Inhibition of Glycogen Synthase Kinase-3β

In this article (Mol Cancer Ther 2009;8:914-20), which was published in the April 1, 2009 issue of Molecular Cancer Therapeutics (1), Figures Figures22 and and33 contained incorrect abbreviations for tautomycin and tautomycetin. The correct abbreviation for tautomycin is TTY, and the correct abbreviation for tautomycetin is TMC. The correct Figures Figures22 and and33 appear here.

figure nihms-194856-f0002
figure nihms-194856-f0003
figure nihms-194856-f0001

Reference

1. Adler JT, Cook M, Luo Y, et al. Tautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3β Mol Cancer Ther. 2009;8:914–20. [PMC free article] [PubMed]